Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W7GH
|
||||
| Former ID |
DIB006773
|
||||
| Drug Name |
IC-747
|
||||
| Synonyms |
LFA-1 antagonists, ICOS/Biogen
|
||||
| Indication | Psoriasis [ICD9: 696; ICD10:L40] | Discontinued in Phase 2 | [547348] | ||
| Company |
ICOS Corp
|
||||
| Canonical SMILES |
S(c1c(cc(cc1)Cl)Cl)c1c(cc(N)cc1)Cl.Cl
|
||||
| CAS Number |
CAS 300808-34-8
|
||||
| Target and Pathway | |||||
| Target(s) | Lymphocyte function-associated antigen 1 | Target Info | Antagonist | [551183] | |
| KEGG Pathway | Rap1 signaling pathway | ||||
| Cell adhesion molecules (CAMs) | |||||
| Natural killer cell mediated cytotoxicity | |||||
| Leukocyte transendothelial migration | |||||
| Regulation of actin cytoskeleton | |||||
| Malaria | |||||
| Staphylococcus aureus infection | |||||
| HTLV-I infection | |||||
| Epstein-Barr virus infection | |||||
| Rheumatoid arthritis | |||||
| Viral myocarditis | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| RANKL Signaling Pathway | |||||
| Pathway Interaction Database | Integrin family cell surface interactions | ||||
| Beta2 integrin cell surface interactions | |||||
| CXCR3-mediated signaling events | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.